Evidence map›Paper›PMID 30236129›Full record

ArticleOrphanet journal of rare diseases2018

Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.

Natacha Kadlub, Quentin Sessiecq, Marion Mandavit, Aurore Coulomb L'Hermine, Cecile Badoual, Louise Galmiche, Ariane Berdal, Vianney Descroix, Arnaud Picard, Amélie E Coudert

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Cherubism with orbital involvement.Indian journal of ophthalmology · 2020
    Article
  6. Article
  7. Article
  8. Molecular findings in maxillofacial bone tumours and its diagnostic value.Virchows Archiv : an international journal of pathology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Natacha KadlubINSERM, UMRS 1138 Equipe 5, Laboratoire de Physiopathologie Orale Moléculaire, Centre de Recherche de Cordeliers, 75006, Paris, France. natacha.kadlub@gmail.com.ORCID 0000-0001-5961-4064
Quentin SessiecqCHU de Bordeaux, Service de Chirurgie Maxillofaciale, 33000, Bordeaux, France.
Marion MandavitINSERM U 970, Equipe 10, PARCC, faculté Paris Descartes, 75015, Paris, France.
Aurore Coulomb L'HermineAPHP, Hôpital Armand Trousseau, Service d'Anatomopathologie et cytologie, 75012, Paris, France.
Cecile BadoualUniversité Paris Descartes, 75006, Paris, France.
Louise GalmicheUniversité Paris Descartes, 75006, Paris, France.
Ariane BerdalINSERM, UMRS 1138 Equipe 5, Laboratoire de Physiopathologie Orale Moléculaire, Centre de Recherche de Cordeliers, 75006, Paris, France.
Vianney DescroixINSERM, UMRS 1138 Equipe 5, Laboratoire de Physiopathologie Orale Moléculaire, Centre de Recherche de Cordeliers, 75006, Paris, France.
Arnaud PicardINSERM, UMRS 1138 Equipe 5, Laboratoire de Physiopathologie Orale Moléculaire, Centre de Recherche de Cordeliers, 75006, Paris, France.
Amélie E CoudertINSERM, UMRS 1138 Equipe 5, Laboratoire de Physiopathologie Orale Moléculaire, Centre de Recherche de Cordeliers, 75006, Paris, France.
Délégation Paris 5 · FRInserm · FRCentre Hospitalier Universitaire de Bordeaux · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCherubism is a rare autosomal dominant disorder of the jaws caused by mutation of the SH3BP2 gene. The bone is replaced by a fibrous granuloma containing multinucleated giant cells. Cells of the cherubism granuloma have never been systematically analyzed. Hence, the aim of this study was to characterize the cells in human cherubism granulomas, to determine the osteoclastic characteristics of the multinucleated giant cells and to investigate the potential role of TNF-α in human cherubism.

resultsSeven granulomas were analyzed in pathology, molecular biology and immunohistochemistry. Granulomas were composed mainly of macrophages or osteoclasts within a fibroblastic tissue, with few lymphoid cells. Myeloid differentiation and nuclear NFATc1 localization were both associated with disease aggressiveness. OPG and RANKL immunohistochemical expression was unexpected in our specimens. Five granuloma cells were cultured in standard and osteoclastogenic media. In culture, cherubism cells were able to differentiate into active osteoclasts, in both osteoclastogenic and standard media. IL-6 was the major cytokine present in the culture supernatants.

conclusionMultinucleated giant cells from cherubism granulomas are CD68 positive cells, which differentiate into macrophages in non-aggressive cherubism and into osteoclasts in aggressive cherubism, stimulated by the NFATc1 pathway. This latter differentiation appears to involve a disturbed RANK-L/RANK/OPG pathway and be less TNF-α dependent than the cherubism mouse model.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAdultCell DifferentiationCherubismChildFemaleHumansImmunohistochemistryInterleukin-6Leukocytes, MononuclearMaleMiddle AgedMutationNFATC Transcription FactorsOsteoclastsAdaptor Proteins, Signal TransducingInterleukin-6NFATC1 protein, humanNFATC Transcription FactorsOsteoprotegerinRANK LigandReceptors, Tumor Necrosis Factor, Type ISH3BP2 protein, humanVimentinAuto-inflammatory bone diseaseCherubismNFATc1OsteoclastRANKLTNF-α

Identifiers

PMID30236129
PMCPMC6148781
OpenAlexW2891736159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.